Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease(REAL-CAD).
Phase of Trial: Phase IV
Latest Information Update: 22 May 2018
At a glance
- Drugs Pitavastatin (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms REAL-CAD
- 15 May 2018 Status changed from active, no longer recruiting to completed.
- 08 May 2018 Primary endpoint of composite of cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, or unstable angina requiring emergency hospitalization has been met, accoring to results published in the Circulation.
- 08 May 2018 Results published in the Circulation